1-(4-(tert-Butyl)benzyl)piperidine-4-carboxylic acid

Catalog No. :
ACCPMS885
CAS No. :
872991-72-5
Molecular Formula :
C17H25NO2
Molecular Weight :
275.39

IUPAC Name:1-(4-(tert-butyl)benzyl)piperidine-4-carboxylic acid

1-(4-(tert-Butyl)benzyl)piperidine-4-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$181.00Login to see priceInquiryInquiry
5g97%$544.00Login to see priceInquiryInquiry
10g97%$816.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(4-(tert-Butyl)benzyl)piperidine-4-carboxylic acid
IUPAC Name1-(4-(tert-butyl)benzyl)piperidine-4-carboxylic acid
MDL No.MFCD05169754
Molecular FormulaC17H25NO2
Molecular Weight275.39
SMILESO=C(C1CCN(CC2=CC=C(C(C)(C)C)C=C2)CC1)O
InChI KeyZDDQVNMLECIPQP-UHFFFAOYSA-N
SynonymN-(4-TERT-BUTYLBENZYL)PIPERIDINE-4-CARBOXYLIC ACID;1-(4-TERT-BUTYL-BENZYL)-PIPERIDINE-4-CARBOXYLIC ACID;4-Piperidinecarboxylic acid, 1-[[4-(1,1-dimethylethyl)phenyl]methyl]-;1-[(4-tert-butylphenyl)methyl]piperidine-4-carboxylic acid
CAS No.872991-72-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACCPMS885 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACIWFN675 route compound structure diagram
    ACIWFN6755984-56-5 In Stock
  4. Then
  5. ACCPMS885 route product structure diagram
    ACCPMS885872991-72-5
Inquiry

2. ACCPMS885 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCPMS885 route product structure diagram
    ACCPMS885872991-72-5
Inquiry

Comments (0)